Viewing Study NCT03242460

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-05-17 @ 3:47 PM
Study NCT ID: NCT03242460
Status: COMPLETED
Last Update Posted: 2020-02-20
First Post: 2017-08-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM)
Sponsor: Kosin University Gospel Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed and/or refractorY Multiple Myeloma View
Keywords: